Cl influx in cells expressing functional CFTR and grown on permeable support. Northern hybridizations indicated the induction of downregulated in adenoma (DRA) in cells expressing functional CFTR. The expression of putative anion transporter PAT1 also increased significantly in cells expressing functional CFTR. DRA was detected at high levels in native mouse pancreas by Northern hybridization and localized to the apical domain of the duct cells by immunohistochemical studies. In conclusion, CFTR upregulates DRA and PAT1 expression in cultured pancreatic duct cells. We propose that the pancreatic HCO 3 Ϫ secretion defect in CF patients is partly due to the downregulation of apical Cl Ϫ / HCO 3 Ϫ exchange activity mediated by DRA (and possibly PAT1). cystic fibrosis; HCO 3 Ϫ secretion; membrane proteins; gene regulation THE EXCRETORY DUCT SYSTEM of the pancreas serves as a conduit for delivery of an alkaline, HCO 3 Ϫ -rich fluid to the duodenum (5, 7) . This HCO 3 Ϫ -rich fluid is secreted in response to the release of secretin by S cells in proximal duodenum on exposure to the acidic chyme emptying from the stomach (5, 7, 19) . Secretin is subsequently delivered to the pancreas (via blood) where it stimulates HCO 3 Ϫ secretion (5, 7, 19) . Studies (7, 17, 19) examining the mechanism(s) of HCO 3 Ϫ transport in pancreatic ducts demonstrate that stimulation of the pancreas with secretin increases both the volume and HCO 3 Ϫ concentration of pancreatic juice. Given the fact that Ͼ90% of the HCO 3 Ϫ in the pancreatic juice is derived from the plasma (5, 7), it becomes evident that specialized and high-capacity acid-base transporters are responsible for active HCO 3 Ϫ secretion into the pancreatic lumen.
Cystic fibrosis (CF), which is an autosomal recessive disease and results from mutational inactivation of a cAMP-sensitive Cl Ϫ channel, manifests itself with impairments in the respiratory, pancreatic, hepatobiliary, and genitourinary systems (27) . The pancreatic dysfunction is felt to result primarily from impairment of secretin-stimulated ductal Cl Ϫ and HCO 3 Ϫ secretion (11, 17, 19) . Based on histopathological evidence, it has been postulated that the reduction in secretin-stimulated HCO 3 Ϫ secretion from pancreatic duct epithelial cells alters intraductal pH sufficiently to precipitate proteins secreted from acinar cells. This should result in protein plugs and the disruption of vesicular trafficking in the apical domain of the acinar cell (12, 28) . These alterations would lead to pancreatic fibrosis and insufficiency in the majority of CF patients (28) .
The currently accepted model of pancreatic ductal HCO 3 Ϫ secretion suggests that intracellular HCO 3 Ϫ is accumulated in response to the action of cytosolic carbonic anhydrase on the CO 2 that diffuses from the basolateral membrane. The G protein-coupled receptors (e.g., secretin and vasoactive intestinal peptide) activate cAMPsensitive CF transmembrane conductance regulator (CFTR), which secretes Cl Ϫ into the lumen. (31) .
Recent studies from our laboratory (31) suggested that 1) HCO 3 Ϫ uptake across the basolateral mem-branes of cultured pancreatic duct cells is mediated via NBC and 2) cAMP potentiates NBC activity through activation of CFTR-mediated Cl Ϫ secretion. It was proposed that the defect in agonist-stimulated ductal HCO 3 Ϫ secretion in patients with CF is partly due to decreased NBC-driven HCO 3 Ϫ entry at the basolateral membrane secondary to the lack of a sufficient electrogenic driving force in the absence of functional CFTR (31, 39) . The role of apical HCO 3 Ϫ transporters and their possible regulation by CFTR were not examined in those experiments.
Studies (20) in perfused pancreatic ducts indicated a decrease in apical Cl Ϫ /HCO 3 Ϫ exchanger activity in CF mice. The identity of the apical exchanger was, however, not determined (18) . Molecular cloning studies have identified three Cl Ϫ /HCO 3 Ϫ exchanger isoforms that are referred to as anion exchangers (AE1, AE2, and AE3) (2, 18) . AE1 and AE3 show a limited tissue expression pattern whereas AE2 is more widespread. The expression of AE isoforms (AE1, AE2, and AE3) in epithelial issues is limited to the basolateral membrane domain. Recent studies (22, 23, 37) have identified a new family of Cl Ϫ /base exchangers. These transporters have a distinct and limited tissue expression pattern and share no significant homology to AEs. Three members of this family, downregulated in adenoma (DRA or SLC26A3), pendrin (PDS or SLC26A4), and the putative anion transporter (PAT1 or SLC26A6), are located on the apical domain of epithelial cells (11, 13, 14, 22, 23, 30, 37) . Functional studies have demonstrated that DRA and pendrin are actually Cl Ϫ /HCO 3 Ϫ exchangers (23, 37) . The functional identity of PAT1, which is expressed on the apical membrane of the pancreatic duct cells (22) , remains unknown at the present. Based on its high homology to DRA and pendrin and its location in the pancreas, it was postulated that PAT1 could be an apical Cl Ϫ /HCO 3 Ϫ exchanger in the duct cells (22) . We have examined the expression of pendrin, DRA, and PAT1 in native mouse pancreas and in cultured CF pancreatic duct cells transfected with a functional CFTR to achieve better insight into the mechanism of pancreatic HCO 3 Ϫ secretion defect in CF. The results indicate that DRA is located on the apical membranes of pancreatic duct cells and regulated by functional CFTR. PAT1 is expressed in the duct cells and upregulated by CFTR. Pendrin could not be detected in the duct cells. These observations may have important implications regarding the pathophysiology of the pancreatic HCO 3 Ϫ secretion defect in CF.
MATERIALS AND METHODS
Cell lines. CFPAC-1, a pancreatic duct cell line derived from a patient with CF and bearing a ⌬F508 mutation, was cultured as previously described (29, 31) . Stably transfected CFPAC-1 cells bearing functional CFTR (termed CFPAC-WT) were generous gifts from Dr. Raymond Frizzell and were cultured in a similar fashion except for the addition of G418 (1 mg/ml) to the medium (31) . Two independent CFPAC-1 clones (obtained in our laboratory) and two other CFPAC-WT clones (gifts from Dr. Frizzell) were further tested to verify the results.
Cell pH measurement. Changes in intracellular pH (pHi) were monitored using the acetoxymethyl ester of the pHsensitive fluorescent dye 2Ј,7Ј-bis(2-carboxyethyl)-5(6)-carboxyfluorescein (BCECF-AM) as described previously (3, 4, 38) . Cells were grown to confluence on glass coverslips and incubated in the presence of 5 M BCECF in a solution consisting of 115 mM tetramethylammonium (TMA) Cl (or NaCl), 25 mM 1 KHCO 3 Ϫ , and 10 mM HEPES, pH 7.4, and gassed with 5% CO 2-95% O2. The monolayer was then perfused with the appropriate solutions in a thermostatically controlled holding chamber (37°C) in a Delta Scan dual excitation spectrofluorometer (PTI, South Brunswick, NJ). The fluorescence ratio at excitation wavelengths of 500 and 450 nm was utilized to determine pH i values. Calibration curves were established daily by measuring five separate pH points using the KCl-nigericin technique. HCO 3 Ϫ -free or -containing solutions were used to determine the HCO 3 Ϫ dependence of the transporters.
To (10) and assayed for DIDS-sensitive and -insensitive 36 Cl Ϫ uptake from the lower (basolateral surface) or upper compartment (apical surface). The integrity of the confluent cell monolayer was assessed by a lack of significant transport of 36 
Cl
Ϫ from the upper compartment to the lower compartment under control conditions (Ͻ0.1% of the 36 
Ϫ appeared in the lower compartment after 5 min). The culture medium was aspirated, and both surfaces were washed in a solution consisting of 140 mM chloride salt of N-methyl-D-glucamine (NMDG), pH 7.4. For uptake experiments across the lower compartment (basolateral surface), 500 M DIDS and 200 M glybenclamide were added to the solution in the upper compartment to inhibit apical AE and Cl Ϫ channels, respectively. For uptake experiments across the upper compartment (apical surface), 500 M DIDS and 200 M glybenclamide were added to the solution in the lower compartment to inhibit basolateral AE and K ϩ channels, respectively. In separate studies, we determined that 200 M glybenclamide alone did not inhibit Cl Ϫ exchange and Na ϩ -dependent-HCO 3 Ϫ cotransport (NBC) in cultured pancreatic duct (CFPAC-WT) cells by 36% and 43%, respectively, in cells grown on coverslips (P Ͻ 0.05 and 0.02 vs. no glybenclamide, n ϭ 5 for each group). We therefore used 200 M glybenclamide in our experiments to avoid any effect on the activity of acid-base transporters.
For radiolabeled flux studies, the solution in the lower compartment (basolateral surface) or the upper compartment (apical surface) was replaced with an uptake medium consisting of 10 mM 36 
Ϫ salt of TMA and 130 mM NMDG gluconate, pH 7.4. The reaction was terminated at 4 min using cold saline. The experiments were performed in the presence or absence of 500 M DIDS. For uptake experi-ments across the apical surface, 0.5 mM DIDS was added to the lower compartment to inhibit the basolateral AE. The uptake experiments across the apical surface were performed in a manner similar to those for the basolateral surface.
RNA isolation and Northern blot hybridization. Total cellular RNA was extracted from CFPAC-1 and CFPAC-WT cells according to the established methods (9), quantitated spectrophotometrically, and stored at Ϫ80°C. Total RNA samples (30 g/lane) were fractionated on a 1.2% agaroseformaldehyde gel, transferred to Magna NT nylon membranes, cross-linked by ultraviolet light, and baked. Hybridization was performed according to Church and Gilbert (10), using [ 32 P]dCTP (NEN, Boston, MA)-labeled cDNA probes. The membranes were washed, blotted dry, and exposed to a PhosphorImager screen (Molecular Dynamics, Sunnyvale, CA). A 400-bp cDNA from the mouse DRA cDNA (EcoRIEcoRI fragment) and a 1.8-kb cDNA from human DRA cDNA [expressed sequence tag (EST) GenBank accession no. AI805046, nt 1058-2858] were used for DRA Northern hybridizations (the mouse probe has Ͼ95% homology to the human DRA and identifies an identical band). For PDS, the full-length human cDNA obtained from a thyroid cDNA library was used as a probe (37) . For the human PAT1 probe, a 2.5-kb RT-PCR product was obtained from human CF-PAC-1 cells using sense and antisense primers with the following sequences: 5Ј-ATG CCT TCA CTG TGT CTC TCT GGT CTT GCC and 5Ј-AAT ATG CAC CAG TTC CCT CCC TGT ACC GC. This fragment encodes nt 175 to 2699. For mouse PAT1, a 200-bp fragment was amplified by RT-PCR from a mouse EST (GenBank accession no. AI747461) using the sense and antisense oligonucleotide primers 5Ј-GGG AGA TTG AAG TGG AAG TGT ACA TC and 5Ј-AAG GCC AGA CTG ACT GCA ATA C. This PCR product corresponds to the mouse sequence nt 2278 to 2468. A ϳ650-bp cDNA (SacI-Bgl2 fragment, nt 731-1379) from AE-1 cDNA, a ϳ1.6-kb fragment (codons 456-1002) from AE-2 cDNA, and a ϳ600-bp cDNA (SmaI-SmaI fragment, nt 28-625) from AE-3 cDNA of rat were used as specific probes. For quantitation of Northern hybridization results, analysis of hybridzation intensities was performed with ImageQuant software, using grid volume measurement and background subtraction by grid-perimeter pixel averaging. Image volumes were normalized by dividing each grid cell volume (DRA, PDS, PAT1, or 28S band intensity) by the mean grid cell volume (band intensity) from an individual blot. Normalized grid cell volumes were then divided by the normalized 28S rRNA for the same gel lane to give DRA (or PAT1) mRNA-to-28S rRNA ratio for that sample.
Immunocytochemistry of DRA in mouse pancreas. Pancreas from normal mice was cut into slices and mounted on holders to form tissue blocks. The tissues were fixed in a solution containing 0.1% glutaraldehyde plus 2% paraformaldehyde in 0.1 M sodium cacodylate buffer, pH 7.2, and stored in 0.1 M cacodylate buffer, pH 7.2 at 4°C. For immunohistochemistry, the tissue blocks were sectioned into 5-m sections, placed on slides (Fisher Superfrost/Plus), and incubated at 75°C in the oven for 1 h. The slides were placed in 1% ZnSO4 in distilled H2O and heated in a microwave twice for 5 min, then cooled at room temperature for 15 min, and washed in distilled H2O twice for 3 min and in PBS twice for 3 min. To block the nonspecific binding, the slides were blotted, treated with a normal rabbit serum in a dilution of 1:10 in PBS plus 1% BSA, and incubated in a humidified chamber for 30 min at room temperature. A DRA-specific antibody (26) was applied to the slides in 1:100 dilution in PBS plus 1% BSA and the presence of saponin and incubated in a humidified chamber for 2 h at room temperature. The specificity of the DRA antibody has been demonstrated in colonocytes (26) . The slides were washed three times in 200 ml PBS supplemented with horse serum at 6, 4, and 2 ml for 5, 5, and 10 min, respectively, at room temperature. The secondary antibody was applied to the slides in a dilution of 1:25. Each slide was treated in 4 l secondary antibody, 5 l normal horse serum, and 91 l PBS plus 1% BSA, incubated in a humidified chamber for 1 h at room temperature, and then washed in PBS three times for 2 min each. The peroxidase-anti-peroxidase conjugate diluted in 1:100 in PBS plus 1% BSA was applied to the slides. Thereafter, the slides were incubated in a humidified chamber for 1 h at room temperature and then washed in PBS three times for 2 min each. To develop a colored reaction product, diaminobenzidine was used. Finally, the tissues were counterstained with Harris hematoxylin and mounted onto the slide using Fluoromount-G and covered with cover glass.
PAT1 antibody generation and immunoblot analysis. Polyclonal antibodies were raised in two rabbits against mouse PAT1 using a synthetic peptide with amino acid sequence MDLRRRDYHMERPLLNQEHL. The preimmune and immune sera of the third bleed were purified by an IgG purification kit (Sigma) and used for immunoblot analysis. Microsomes from cultured CFPAC-1 and CFPAC-WT cells were prepared and resolved by SDS-PAGE (30 g/lane) and transferred to nitrocellulose membrane. The membrane was blocked with 5% milk proteins and then incubated for 6 h with 40 l of PAT1 immune serum diluted at 1:400. The secondary antibody was a donkey anti-rabbit IgG conjugated to horseradish peroxidase (Pierce Chemical, Rockford, IL). The site of antigen-antibody complexation on the nitrocellulose membranes was visualized using the chemiluminescence method (SuperSignal Substrate, Pierce) and captured on light-sensitive imaging film (Kodak).
Statistical analyses. Values are expressed as means Ϯ SE. The significance of difference between mean values was examined using ANOVA. P Ͻ 0.05 was considered statistically significant.
RESULTS

Cl
Ϫ /HCO 3 Ϫ exchange activity in pancreatic duct cells. In this series of experiments, Cl Ϫ /HCO 3 Ϫ exchange activity was assayed in CFPAC-1 and CFPAC-WT cells grown on coverslips. Representative tracings (Fig. 1A) along with the summary of six separate experiments (Fig. 1B) 3 Ϫ exchange activity was inhibited by ϳ84 Ϯ 5% and 76 Ϯ 5% in CFPAC-1 and CFPAC-WT cells, respectively, in the presence of 500 M DIDS (P Ͻ 0.05 for both cell types vs. no DIDS, n ϭ 6 for each group).
The functional assay in Fig. 1B measures total Cl Ϫ / HCO 3 Ϫ exchange activity, as both apical and basolateral transporters are accessible in cells grown on coverslips. To determine the apical Cl Ϫ /HCO 3 Ϫ exchange activity, 36 
Ϫ influx across the luminal surface of cultured duct cells grown on permeable support was measured. Cells were grown to confluence in 30-mm Millicell-HA culture dish inserts for 10-12 days and assayed for radiolabeled influx studies as described in MATERIALS AND METHODS. The experiments were performed in the presence or absence of DIDS. As indicated in Fig. 1C , both DIDS-sensitive and -insensitive luminal 36 Cl Ϫ influx increased in cells transfected with functional CFTR (P Ͻ 0.01 vs. CFPAC-1 cells for both DIDS-sensitive and -insensitive components), indicating the upregulation of apical AE by CFTR in cultured pancreatic duct cells. In the presence of 100 mM unlabeled Cl Ϫ in the luminal compartment, the absolute 36 Cl uptake (in counts/min) decreased as expected due to competition with the unlabeled Cl Ϫ ; however, the pattern of increase in DIDS-sensitive and -insensitive 36 Cl influx in CFAPAC-WT cells remained similar to the low Cl Ϫ uptake solution. Contrary to the luminal surface, the DIDS-sensitive 36 Cl Ϫ influx across the basolateral surface was decreased by 33% in cells transfected with functional CFTR (P Ͻ 0.05 vs. CFPAC-1 cells), indicating the downregulation of basolateral AE by CFTR in cultured pancreatic duct cells. The DIDS-insensitive 36 Cl influx across the basolateral membrane remained unchanged in CFPAC-WT cells. /base exchanger in CFPAC-WT cells, we examined the expression of a number of AEs by Northern hybridization. AE1 and AE3 were not detected. Interestingly, the expression of the ubiquitous AE2 was actually decreased in cells expressing the functional CFTR ( Fig.  2A) , with the AE2 mRNA decreasing by ϳ40% in CF-PAC-WT cells (P Ͻ 0.05, n ϭ 3). These results indicate that none of these AEs are responsible for enhanced apical Cl Ϫ /base exchanger. Next we examined the expression of DRA in pancreatic duct cells. We performed Northern blots on three independent CFPAC-WT clones (gifts from Dr. Frizzell) and CFPAC-1 clones (developed in our laboratory). We examined three independent clones from each cell line to make sure that the results reflected the presence of the functional CFTR and were not due to a possible clonal selection process. Northern hybridizations indicated that DRA mRNA was expressed in functional CFTR-bearing duct epithelial cells but could not be detected in CFPAC-1 cells expressing a mutant CFTR (Fig. 2B) .
Functional CFTR induces expression of Cl
Expression and localization of DRA in mouse pancreas. To determine whether DRA is expressed in native pancreatic tissue, poly(A) ϩ RNA from mouse pancreas (Clonetech) was used for Northern hybridization. The results, shown in Fig. 3 , demonstrate that the mouse pancreas expresses high levels of DRA mRNA.
We next examined the localization of DRA in mouse pancreas by immunohistochemical staining. As demon- strated in Fig. 4 , top, the DRA immune serum labeled the apical membrane of the duct cells. In addition to the apical labeling, cytoplasmic staining was also detected in the pancreatic duct cells. No staining was detected in acinar cells. Staining with a nonimmune serum did not show any labeling in the duct cells (Fig.  4, bottom) . Taken together, Figs. 3 and 4 demonstrate that DRA is expressed in the pancreas and localized to the apical membrane of the duct cells. Expression of pendrin and PAT1. Recently (37), pendrin, which is highly homologous and adjacent to DRA on chromosome 7 (11), was found to mediate apical Cl Ϫ /HCO 3 Ϫ exchange in kidney intercalated cells. In the present study, no detectable levels of pendrin mRNA could be observed in cultured duct cells (data not shown).
Recent (22) cloning experiments have identified a new transporter, PAT1, with high homology to DRA and pendrin. PAT1 is expressed in pancreas and kidney (22) . Immunocytochemical studies localized PAT1 to the apical membranes of the pancreatic duct cells (22) . Figure 5A examines the expression of PAT1 in cultured duct cells and indicates that the expression of PAT1 is enhanced by approximately fivefold in CF duct cells transfected with functional CFTR. To determine whether enhanced expression of PAT1 is associated with increased protein abundance, immunoblot analysis studies were performed as described in MATERIALS AND METHODS. A representative immunoblot analysis is shown in Fig. 5B and demonstrates that the abundance of PAT1, which appears as a ϳ95-kDa band, is increased in CFPAC-WT cells (densitometric analysis of the blots showed that PAT1 abundance is increased by 130%, n ϭ 3, P Ͻ 0.03). Figure 5B also shows that preadsorption of the immune serum with the synthetic peptide blocks the labeling of the 95-kDa band.
DISCUSSION
The results of current experiments demonstrate that DRA is expressed in mouse pancreas and localized to the apical domain of the duct cells (Figs. 3 and 4) . DRA expression was also detected in cultured human pancreatic duct cells and found to be upregulated by functional CFTR (Fig. 2) . The upregulation of DRA was associated with enhanced apical Cl Ϫ /HCO 3 Ϫ exchanger activity (Fig. 1) . In addition to DRA, Northern hybridizations and immunoblot analysis demonstrated enhanced expression of PAT1 in pancreatic duct cells transfected with functional CFTR (Fig. 5) . Basolateral Cl Ϫ /HCO 3 Ϫ exchange activity, along with AE2 mRNA, was decreased in cells with functional CFTR (see RE-SULTS).
DRA protein, which has been shown (13, 14) to mediate sulfate, oxalate, and Cl Ϫ transport in Xenopus oocytes, was recently shown (23) to be a Cl Ϫ /HCO 3 Ϫ exchanger. DRA was originally cloned via subtractive hybridization in a colon cDNA library (30) . Its function was not known at the time of its cloning. Subsequently, it was found that patients with congenital chloride diarrhea, which lack apical Cl Ϫ /HCO 3 Ϫ exchange activity in their colon, had null mutations in DRA (14) . Transfection of HEK-293 cells with DRA cDNA demonstrated that DRA mediates Cl Ϫ /HCO 3 Ϫ exchange activity (23) . On the basis of these results, it has been proposed that DRA is an apical AE in the colon (14, 23, 26, 34) . HCO 3 Ϫ secretion in pancreatic duct cells is partly mediated via apical Cl Ϫ /HCO 3 Ϫ exchanger (5, 7, 35) . The identity of this exchanger, however, has not been identified. The current experiments indicate that DRA is located on the apical membrane of the pancreatic duct cells (Fig. 4) . Coupled to functional studies (23) indicating that DRA is a Cl Ϫ /HCO 3 Ϫ exchanger, we propose that this exchanger is an apical AE in the duct cells and therefore plays an important role in pancreatic HCO 3 Ϫ secretion. PAT1 was recently cloned based on homology to DRA and pendrin (22) . PAT1 maps to chromosome 3 and encodes a 738-amino-acid protein (22) . Immunohistochemical studies (22) localized PAT1 to the apical membranes of the pancreatic duct cells. The functional identity of PAT1 remains unknown; however, based on its homology to DRA and pendrin, it has been suggested to be an apical Cl Ϫ /HCO 3 Ϫ exchanger in pancreatic duct cells (22) . Interestingly, CF cells transfected with functional CFTR demonstrated enhanced mRNA and protein expression of PAT1 (Fig. 5) .
Increased Cl Ϫ /HCO 3 Ϫ exchanger activity in pancreatic duct cells expressing a functional CFTR (CFPAC-WT) (Fig. 1) is likely due to the upregulation of DRA and possibly PAT1 ( Figs. 2A and 5 ). This is in agreement with recent studies (20) 26 for specificity) was used for immunohistochemical staining. As indicated, DRA labels the apical membrane of the duct cells (top). No labeling was observed with nonimmune serum (Fig. 4,  bottom) . is further plausible that another apical HCO 3 Ϫ transporter (i.e., a HCO 3 Ϫ -conductive pathway) mediates the rest of HCO 3 Ϫ secretion in pancreatic duct cells. This is very important, as HCO 3 Ϫ concentrations in excess of 130 mM cannot be achieved by apical Cl Ϫ /HCO 3 Ϫ exchanger action alone (15, 35) . Whether the HCO 3 Ϫ conductive pathway is indeed the same as CFTR or a channel regulated by CFTR remains to be determined.
The mechanism of the upregulation of DRA or PAT1 by CFTR remains speculative. CFTR is a cAMP-sensitive Cl Ϫ channel, and its activation can affect a number of parameters including intracellular Cl Ϫ , membrane potential, or cell pH. Any increase in the mRNA expression of DRA or PAT1 should, however, result from signals that permeate the cell nucleus. Whether changes in cytoplasmic parameters (i.e., membrane potential or Cl Ϫ concentration) can be transmitted to the nucleus and affect the expression of DRA or PAT1 remains to be determined. The present studies were performed using an in vitro expression system. It remains to be determined whether altered expression of Cl Ϫ /HCO 3 Ϫ exchangers (DRA, PAT1, and AE2) by CFTR is a phenomenon that is also observed in vivo.
Recent studies from our (31) laboratory indicated that activation of CFTR in functional CFTR-bearing duct cells (CFPAC-WT cells), but not in cells expressing a mutant CFTR (CFPAC-1 cells), stimulated the electrogenic NBC via membrane depolarization resulting from Cl Ϫ secretion (24) . According to these studies (31), NBC mediates the uptake of HCO 3 Ϫ at the basolateral membrane of normal pancreatic duct cells (1, 16, 31, 36, 39) . This transporter is enhanced in response to secretin-stimulated membrane depolarization that results from CFTR activation (24, 31) . Our current study indicates that the HCO 3 Ϫ that enters the duct cells is then secreted at the apical membrane via Cl Ϫ /HCO 3 Ϫ exchanger DRA and possibly PAT1 (and another yet-to-be identified-HCO 3 Ϫ transporter). Based on the current studies and the available literature, we propose that the HCO 3 Ϫ secretion defect in CF duct cells may involve transporters in both basolateral and apical membrane domains. In CF, the basolateral NBC activity decreases due to the lack of adequate membrane depolarization (which normally results from CFTR activation). Furthermore, the exit of HCO 3 Ϫ across the apical membrane is decreased due to the downregulation of apical DRA (and possibly PAT1).
In conclusion, the apical transporter DRA (and PAT1) is upregulated by functional CFTR and increases the Cl Ϫ /HCO 3 Ϫ exchanger activity in cultured pancreatic duct cells. We propose that the pancreatic HCO 3 Ϫ secretion defect in patients with CF is partly due to the downregulation of the apical Cl Ϫ /HCO 3 Ϫ exchange activity mediated by DRA (and possibly PAT1). Additional studies are needed to determine the molecular mechanism of transcriptional upregulation of DRA and PAT1 by CFTR.
